147 related articles for article (PubMed ID: 11798009)
1. Attenuation of morphine withdrawal signs by the GABA(B) receptor agonist baclofen.
Bexis S; Ong J; White J
Life Sci; 2001 Dec; 70(4):395-401. PubMed ID: 11798009
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR
Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832
[TBL] [Abstract][Full Text] [Related]
3. Effects of Injection of Gamma-Aminobutyric Acid Agonists into the Nucleus Accumbens on Naloxone-Induced Morphine Withdrawal.
Topkara B; Yananli HR; Sakallı E; Demirkapu MJ
Pharmacology; 2017; 100(3-4):131-138. PubMed ID: 28637045
[TBL] [Abstract][Full Text] [Related]
4. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice.
Zarrindast MR; Mousa-Ahmadi E
Eur J Pharmacol; 1999 Sep; 381(2-3):129-33. PubMed ID: 10554880
[TBL] [Abstract][Full Text] [Related]
5. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
Belozertseva IV; Andreev BV
Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of morphine withdrawal signs by muscimol in the locus coeruleus of rats.
Mirzaii-Dizgah I; Karimian SM; Hajimashhadi Z; Riahi E; Ghasemi T
Behav Pharmacol; 2008 May; 19(3):171-5. PubMed ID: 18469534
[TBL] [Abstract][Full Text] [Related]
7. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
[TBL] [Abstract][Full Text] [Related]
8. The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat.
Brebner K; Froestl W; Roberts DC
Psychopharmacology (Berl); 2002 Feb; 160(1):49-55. PubMed ID: 11862373
[TBL] [Abstract][Full Text] [Related]
9. CGP 36216 is a selective antagonist at GABA(B) presynaptic receptors in rat brain.
Ong J; Bexis S; Marino V; Parker DA; Kerr DI; Froestl W
Eur J Pharmacol; 2001 Mar; 415(2-3):191-5. PubMed ID: 11274998
[TBL] [Abstract][Full Text] [Related]
10. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
Pedrón VT; Varani AP; Balerio GN
Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
[TBL] [Abstract][Full Text] [Related]
11. The γ-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens.
Fu Z; Yang H; Xiao Y; Zhao G; Huang H
Behav Brain Funct; 2012 Jul; 8():20. PubMed ID: 22559224
[TBL] [Abstract][Full Text] [Related]
12. Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects.
Suzuki T; Nurrochmad A; Ozaki M; Khotib J; Nakamura A; Imai S; Shibasaki M; Yajima Y; Narita M
Neuropharmacology; 2005 Dec; 49(8):1121-31. PubMed ID: 16095635
[TBL] [Abstract][Full Text] [Related]
13. GABA mechanisms and antinociception in mice with ligated sciatic nerve.
Zarrindast MR; Mahmoudi M
Pharmacol Toxicol; 2001 Aug; 89(2):79-84. PubMed ID: 11555324
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of morphine withdrawal signs by a D1 receptor agonist in the locus coeruleus of rats.
Dizgah IM; Karimian SM; Zarrindast MR; Sohanaki H
Neuroreport; 2005 Oct; 16(15):1683-6. PubMed ID: 16189477
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracerebroventricular injection of GABA receptor agents on morphine-induced antinociception in the formalin test.
Mahmoudi M; Zarrindast MR
J Psychopharmacol; 2002 Mar; 16(1):85-91. PubMed ID: 11949777
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam.
Koek W; Carter LP; Lamb RJ; Chen W; Wu H; Coop A; France CP
J Pharmacol Exp Ther; 2005 Jul; 314(1):170-9. PubMed ID: 15774716
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological re-evaluation of a GABA(B) receptor antagonist CGP 47332A in rat brain.
Ong J; Marino V; Parker DA; Kerr DI; Froestl W
Eur J Pharmacol; 1999 Oct; 383(2):137-41. PubMed ID: 10585527
[TBL] [Abstract][Full Text] [Related]
19. GABA(B) receptor agonists reverse akinesia following intranigral or intracerebroventricular injection in the reserpine-treated rat.
Johnston T; Duty S
Br J Pharmacol; 2003 Aug; 139(8):1480-6. PubMed ID: 12922935
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological actions of GABAB agonists and antagonists in rat dorso-lateral septal neurones in vitro.
Bon C; Galvan M
Br J Pharmacol; 1996 Jun; 118(4):961-7. PubMed ID: 8799569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
